Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population

Carol Alliot

doi:10.1002/cncr.20707

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population

Cancer ◽

10.1002/cncr.20707 ◽

2004 ◽

Vol 101 (12) ◽

pp. 2897-2898

Author(s):

Carol Alliot

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Elderly Population ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma

Download Full-text

Intensification of radiation therapy by temozolomide and fractionated stereotactic boost in newly diagnosed glioblastoma multiforme: A long-term analysis of a phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e12515 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e12515-e12515

Author(s):

G. R. D'Agostino ◽

G. Chiloiro ◽

S. Manfrida ◽

S. Chiesa ◽

G. Apicella ◽

...

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma ◽

Term Analysis

Download Full-text

Outcomes following Conformal Fractionated Stereotactic Boost and Temozolomide in Newly Diagnosed Glioblastoma Multiforme: A Long Term Analyses of Phase II Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.620 ◽

2010 ◽

Vol 78 (3) ◽

pp. S260

Author(s):

M. Balducci ◽

G. Chiloiro ◽

S. Manfrida ◽

A. Mangiola ◽

G.R. D'Agostino ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma

Download Full-text

Faculty Opinions recommendation of Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7871956.8220054 ◽

2011 ◽

Author(s):

Marc Chamberlain

Keyword(s):

Radiation Therapy ◽

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma

Download Full-text

Phase II study of temozolomide (TMZ) administered on a 7 days on-7 days off regimen as primary treatment before radiotherapy (RT) in inoperable newly diagnosed glioblastoma multiforme (GBM)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.1523 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 1523-1523 ◽

Cited By ~ 4

Author(s):

O. Chinot ◽

M. Barrié ◽

A. Cournède ◽

H. Dufour ◽

D. Figarella-Branger ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Primary Treatment ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma

Download Full-text

Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps151 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS151-TPS151 ◽

Cited By ~ 5

Author(s):

L. B. Nabors ◽

K. Fink ◽

D. A. Reardon ◽

G. J. Lesser ◽

J. Trusheim ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Gene Promoter ◽

Newly Diagnosed ◽

Open Label ◽

Mgmt Gene ◽

Newly Diagnosed Glioblastoma

Download Full-text

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study

Acta Oncologica ◽

10.3109/0284186x.2013.879607 ◽

2014 ◽

Vol 53 (7) ◽

pp. 939-944 ◽

Cited By ~ 15

Author(s):

Kenneth F. Hofland ◽

Steinbjørn Hansen ◽

Morten Sorensen ◽

Silke Engelholm ◽

Henrik P. Schultz ◽

...

Keyword(s):

Glioblastoma Multiforme ◽

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Concomitant Chemoradiotherapy ◽

Randomized Phase Ii ◽

Newly Diagnosed Glioblastoma

Download Full-text